JPMorgan Chase & Co’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.6M | Buy |
|
|||||
|
2022
Q3 | $585K | Buy |
|
|||||
|
2022
Q2 | $195K | Buy |
|
|||||
|
2022
Q1 | $0 | Hold |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $8K | Sell |
|
|||||
|
2021
Q2 | $157K | Sell |
|
|||||
|
2021
Q1 | $787K | Buy |
|
|||||
|
2020
Q4 | $1.99M | Buy |
|
|||||
|
2020
Q3 | $1.04M | Sell |
|
|||||
|
2020
Q2 | $1.15M | Sell |
|
|||||
|
2020
Q1 | $1.16M | Sell |
|
|||||
|
2019
Q4 | $1.55M | Buy |
|
|||||
|
2019
Q3 | $915K | Buy |
|
|||||
|
2019
Q2 | $1.77M | Buy |
|
|||||
|
2019
Q1 | $1.79M | Sell |
|
|||||
|
2018
Q4 | $1.87M | Sell |
|
|||||
|
2018
Q3 | $2.77M | Buy |
|
|||||
|
2018
Q2 | $2.56M | Buy |
|
|||||
|
2018
Q1 | $3.35M | Sell |
|
|||||
|
2017
Q4 | $4.09M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $43K | Sell |
|
|||||
|
2017
Q1 | $900K | Buy |
|
|||||
|
2016
Q4 | $426K | Buy |
|
|||||
|
2016
Q3 | $102K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1K | Sell |
|
|||||
|
2015
Q3 | $564K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.06M | Buy |
|